fda bpc 157 category 2 compounding The just put peptides like BPC-157, TB-500, and KPV on the clock. As a pharmacist, this is literally my world — and most people don't understand the regulatory nuance behind Category 1 vs. Category 2.
Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means FDA Peptide Review 2026: What This Big Shift Means Is BPC 157 Legal in 2026? FDA Compounding Status Explained This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make fda bpc 157 fda bpc 157 category 2 bulk drug substances compounding list Category 1 vs. Category 2. The This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
